Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas

R. K. Ramanathan, D. Goldstein, R. L. Korn, F. Arena, M. Moore, S. Siena, L. Teixeira, J. Tabernero, J. L. Van Laethem, H. Liu, D. McGovern, B. Lu, D. D. Von Hoff

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas'. Together they form a unique fingerprint.

Medicine & Life Sciences